Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6430572rdf:typepubmed:Citationlld:pubmed
pubmed-article:6430572lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:6430572lifeskim:mentionsumls-concept:C0026030lld:lifeskim
pubmed-article:6430572lifeskim:mentionsumls-concept:C0683140lld:lifeskim
pubmed-article:6430572lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:6430572lifeskim:mentionsumls-concept:C0007022lld:lifeskim
pubmed-article:6430572lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6430572lifeskim:mentionsumls-concept:C0023775lld:lifeskim
pubmed-article:6430572lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:6430572lifeskim:mentionsumls-concept:C0072497lld:lifeskim
pubmed-article:6430572pubmed:issue2lld:pubmed
pubmed-article:6430572pubmed:dateCreated1984-8-24lld:pubmed
pubmed-article:6430572pubmed:abstractTextThe effects of cobaltic protoporphyrin IX (CPP) administration on hepatic microsomal drug metabolism, carbon tetrachloride activation and lipid peroxidation have been investigated using male Wistar rats. CPP (125 mumol/kg, 72 h before sacrifice) profoundly decreased the levels of hepatic microsomal heme, particularly cytochrome P-450. Consequently, the associated mixed-function oxidase systems were equally strongly depressed. An unexpected finding was that CPP administration also greatly decreased the activity of NADPH/cytochrome c reductase, a result not generally found with the administration of the more widely used cytochrome P-450 depleting agents, cobaltous chloride. Activation of carbon tetrachloride, measured as covalent binding of [14C] CCl4, spin-trapping of CCl3 and CCl4-stimulated lipid peroxidation, was much lower in liver microsomes from CPP-treated rats. Other microsomal lipid peroxidation systems, utilising cumene hydroperoxide or NADPH/ADP-Fe2+, were also depressed in parallel with the decrease in microsomal enzyme activities.lld:pubmed
pubmed-article:6430572pubmed:languageenglld:pubmed
pubmed-article:6430572pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6430572pubmed:citationSubsetIMlld:pubmed
pubmed-article:6430572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6430572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6430572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6430572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6430572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6430572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6430572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6430572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6430572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6430572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6430572pubmed:statusMEDLINElld:pubmed
pubmed-article:6430572pubmed:monthJullld:pubmed
pubmed-article:6430572pubmed:issn0009-2797lld:pubmed
pubmed-article:6430572pubmed:authorpubmed-author:SlaterT FTFlld:pubmed
pubmed-article:6430572pubmed:authorpubmed-author:TomasiAAlld:pubmed
pubmed-article:6430572pubmed:authorpubmed-author:CheesemanK...lld:pubmed
pubmed-article:6430572pubmed:authorpubmed-author:AldicaNNlld:pubmed
pubmed-article:6430572pubmed:issnTypePrintlld:pubmed
pubmed-article:6430572pubmed:volume50lld:pubmed
pubmed-article:6430572pubmed:ownerNLMlld:pubmed
pubmed-article:6430572pubmed:authorsCompleteYlld:pubmed
pubmed-article:6430572pubmed:pagination143-51lld:pubmed
pubmed-article:6430572pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:meshHeadingpubmed-meshheading:6430572-...lld:pubmed
pubmed-article:6430572pubmed:year1984lld:pubmed
pubmed-article:6430572pubmed:articleTitleThe effect of the administration of cobaltic protoporphyrin IX on drug metabolism, carbon tetrachloride activation and lipid peroxidation in rat liver microsomes.lld:pubmed
pubmed-article:6430572pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6430572pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6430572lld:pubmed